Neglected hepatitis e and typhoid vaccines

The Lancet

Volumn 376, Issue 9744, 2010, Pages 869-

  Basnyat, Buddha ^a  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; RECOMBINANT VACCINE; TYPHOID PARATYPHOID VACCINE;

COMMERCIAL PHENOMENA; DRUG INDUSTRY; EPIDEMIOLOGY; FEMALE; FRANCE; HEPATITIS E; HUMAN; MORTALITY; NEPAL; PATENT; PREGNANCY; PREGNANCY COMPLICATION; STANDARDS; TRENDS; TYPHOID FEVER; UNITED STATES; VIET NAM; VIROLOGY;

COMMERCE; DRUG INDUSTRY; FEMALE; FRANCE; HEPATITIS E; HUMANS; INTELLECTUAL PROPERTY; NEPAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; UNITED STATES; VACCINES, SYNTHETIC; VIETNAM; VIRAL HEPATITIS VACCINES;

EID: 77956606339     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61403-1     Document Type: Letter

References (4)

1. F-C Zhu, J Zhang, X-F Zhang Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial Lancet 376 2010 895 902
2. MP Shrestha, RM Scott, DM Joshi Safety and efficacy of a recombinant hepatitis E vaccine N Engl J Med 356 2007 895 903
3. FY Lin, VA Ho, HB Khiem The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children N Engl J Med 344 2001 1263 1269
4. D De Roeck, L Jodar, J Clemens Putting typhoid vaccine in the global health agenda N Engl J Med 357 2007 1069 1071